A Chemical Characterization Workflow for Nontargeted Analysis of Complex Extracts from Polymer Based Medical Device Using High Resolution LC/MS.

Chemical characterization FISh LC/MS common fragment ion common neutral loss workflow

Journal

ACS biomaterials science & engineering
ISSN: 2373-9878
Titre abrégé: ACS Biomater Sci Eng
Pays: United States
ID NLM: 101654670

Informations de publication

Date de publication:
08 05 2023
Historique:
medline: 9 5 2023
pubmed: 24 4 2023
entrez: 24 04 2023
Statut: ppublish

Résumé

The chemical characterization of extractables and leachables (E&Ls) is an important aspect of biosafety and biocompatibility assessment in medical device industry. The advent of the body-contact use of medical devices in patient treatment has introduced a potential source for extractables and leachables as these medical devices are comprised of various polymeric materials. Several industry working groups, the FDA and USP, have recognized the guidance for chemical characterizations and nontargeted analysis of medical device extracts, such as ISO 10993-18:2020. The MS application of nontargeted analysis has played a critical role in understanding the E&Ls from medical device extracts. However, there have been very few reports about the MS based workflow with nontargeted analysis for medical device extracts and there is little guidance about the exact methodologies which should be used, even though there is an urgent need for a clearly defined process for the identification of medical device extracts. In this study, we demonstrated an analytical LC/MS (liquid chromatography/mass spectrometry) workflow using high resolution Exploris120 Orbitrap instrument for data acquisition and Compound Discoverer 3.3 intelligent software for data processing to profile the polymer related E&Ls from a balloon dilation catheter device extracted with 40% ethanol. An E&L ID workflow combining LC separation, data-informed MS acquisition strategy, MS information mining (including adduct ions, MS information from both electrospray ionization (ESI) (+) and ESI (-), in-source fragmentation, common fragment ions (CFIs), common neutral losses (CNLs), and in silico MS simulation was described with intelligent software processing and manual data interpretation. The workflow developed in this study was proven to be effective to provide a comprehensive profile of polymer related degradation products, polymer impurities and additives including surfactants, UV curing agent, antioxidants, and plasticizers for the device analyzed. The classification of E&L compounds using CFIs and CNLs was very effective to facilitate the identification of polymer related impurities and extract the polymer related impurities with common structures in a large data result set.

Identifiants

pubmed: 37094361
doi: 10.1021/acsbiomaterials.2c01467
doi:

Substances chimiques

Polymers 0
Complex Mixtures 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2277-2291

Auteurs

Haiqiang Yu (H)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Kristen Kiley (K)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Sandeep Kullar (S)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Katherine Fu (K)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Thu Ngoc Tran (TN)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Haibo Wang (H)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Jie Hu (J)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Marika Kamberi (M)

Research and Development, Abbott Vascular Division, Abbott Laboratory, 3200 Lakeside Dr., Santa Clara, California 95054-2807, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH